Brazil Anvisa–MFDS Cosmetics MoU 2026

Agência Nacional de Vigilância Sanitária (Anvisa) has signed a 2026 Memorandum of Understanding (MoU) with South Korea’s Ministry of Food and Drug Safety (MFDS), strengthening regulatory cooperation in cosmetics and public health oversight. The updated agreement builds on the 2014 partnership and enhances collaboration on cosmetics regulation, technical exchange, and regulatory innovation between Brazil and South Korea.

Key Updates in the 2026 Anvisa–MFDS MoU

The new MoU modernizes bilateral cooperation and introduces a stronger regulatory focus on cosmetics.

Main developments include:

• Alignment of cosmetics regulatory standards

• Exchange of technical and scientific expertise

• Cooperation on safety assessment and post-market surveillance

• Information sharing on regulatory innovation

• Joint training and capacity-building initiatives

The agreement reflects growing regulatory complexity in the cosmetics sector, including innovative formulations, digital sales channels, and evolving safety expectations.

Impact on Cosmetics Market Access

Brazil is one of the world’s largest cosmetics markets, while South Korea is globally recognized for advanced skincare innovation. Regulatory alignment between Anvisa and MFDS may support:

• Greater predictability for manufacturers

• Reduced duplication in regulatory assessments

• Improved clarity on compliance requirements

• Strengthened post-market monitoring frameworks

For companies operating in both jurisdictions, closer regulatory dialogue can streamline market entry strategies and reduce compliance risks.

Broader Public Health and Regulatory Cooperation

Although cosmetics are a central focus, the MoU reinforces wider public health collaboration, including:

• Technical meetings and expert exchanges

• Sharing regulatory best practices

• Cooperation in emerging health product challenges

• Support for modern, science-based regulatory frameworks

Such cooperation contributes to global regulatory convergence and strengthens consumer protection systems.

How to Monitor and Comply

Companies exporting cosmetics to Brazil or South Korea should:

1. Review updated regulatory guidance issued by Anvisa and MFDS.

2. Monitor bilateral technical developments affecting ingredient safety and labeling.

3. Align internal compliance processes with evolving regulatory expectations.

4. Engage early with local regulatory representatives when planning new product launches.

Learn more about Brazil regulatory requirements via the official Anvisa portal.

External Reference

• Read the full announcement from Anvisa: Official Anvisa announcement  

Internal Reference

Learn more about:

• ANVISA Brazil Medical Device Registration

• Brazil ANVISA submissions 50% faster with AI

‍